GLP 1 peptider med enorm betydning for hjerte-kar-systemet: Ny mekanisme opdaget!
From the study, additional support was provided by the Novo Nordisk Foundation Tripartite Immunometabolism Consortium (NNF15CC0018486), the British Heart Foundation through grants FS/16/15/32047, PG/13/56/30383, RG/17/10/32859, RG/F/21/110040, a British Heart Foundation Chair Award (CH/16/1/32013), a British Heart Foundation Centre of Research Excellence Award (RG/13/1/30181), and the Swedish Heart Lung Foundation (HLF 20180290).